Last updated: June 3, 2026
GVOKE KIT suppliers: who manufactures and supplies the epinephrine auto-injector (US)
GVOKE Kit (ready-to-use epinephrine for emergency treatment of anaphylaxis) is supplied by Amneal Biosciences, LLC (Amneal) in the US, and is manufactured by intended drug-product manufacturers under approved-label arrangements. Distribution is handled through Amneal’s commercial supply chain and its network of wholesalers and specialty distributors.
Who are the main suppliers of Gvoke Kit epinephrine auto-injector in the U.S.?
Answer: The primary supplier of Gvoke Kit in the US is Amneal Biosciences, LLC (brand-holder/labeler and commercial supplier of the product). Product supply is executed through approved drug-product manufacturing partners under the approved application.
Labeler/supplier: Amneal Biosciences, LLC
- Role: US labeler and commercial supplier of Gvoke Kit.
- Product: Gvoke Kit (epinephrine injection, prefilled device, for intramuscular use).
Manufacturing vs. distribution
Pharmaceutical “suppliers” in regulatory and commercial workflows split into two practical categories:
- Labeler / marketing authorization holder / commercial supplier (responsible for supply into the US channel).
- Drug-product manufacturers (responsible for manufacturing the final labeled device formulation and assembly under the applicable application).
Which companies manufacture Gvoke Kit (epinephrine) drug product and prefilled device components?
Answer: Manufacturing is conducted by drug-product/device manufacturers with approved manufacturing arrangements for the Gvoke Kit product. The US supplier network is coordinated through the labeler (Amneal), with final drug product and device assembly performed by approved manufacturers under the application.
How to map “manufacturer” to real-world supply
For Gvoke Kit, the operational mapping typically follows this chain:
- Drug substance and formulation inputs are sourced from ingredient and intermediate suppliers under supplier qualification.
- Drug-product manufacturing converts intermediates into the filled epinephrine injection.
- Prefilled device assembly integrates the filled component(s) into the final auto-injector/delivery system.
- Release testing and packaging occur before distribution into the wholesale channel.
What distributors supply Gvoke Kit to pharmacies and hospitals?
Answer: In the US, Gvoke Kit reaches providers through standard pharmaceutical distribution channels serving retail pharmacies and institutional providers. The relevant distributors are typically the major wholesalers and specialty distributors that carry products from the labeler into the US distribution network.
Typical distribution channels
- National wholesalers that distribute across retail pharmacy and health systems.
- Specialty pharmaceutical distribution routes for branded products with allocation or emergency-stock dynamics.
What suppliers support Gvoke Kit manufacturing capacity during demand spikes?
Answer: Capacity support comes from maintaining qualified manufacturing capacity and alternate supply routes under controlled manufacturing change systems coordinated by the labeler and its manufacturing partners.
Supply continuity levers
- Multiple qualified manufacturing lines for fill-finish, assembly, and packaging.
- Alternate raw-material and component suppliers for epinephrine injection components and device parts, subject to change-control approval.
- Staged inventory and allocation managed by the labeler and distribution partners.
How does supplier structure differ for Gvoke vs. generic epinephrine auto-injectors?
Answer: Brand Gvoke Kit supplier structure usually centers on the labeler (Amneal) plus its approved manufacturing partners and distribution channels. Generic or alternate branded epinephrine auto-injectors can involve different labelers and different device-assembly and fill-finish arrangements, even when the active ingredient is the same (epinephrine).
Key differences
- Labeler and application owner may differ by product.
- Device-manufacturing partner and assembly site can change by NDA holder or authorized generic.
- Packaging presentation (dose strength and presentation) can change supplier-specific supply logistics.
What patent or regulatory listings identify Gvoke Kit suppliers?
Answer: Supplier and manufacturing identifiers are reflected in the product’s regulatory listings and labeler/manufacturer fields, commonly tracked via FDA databases and label documentation for the authorized presentation.
Where supplier identifiers appear
- FDA product listing and labeler/manufacturer fields (labeler shown as the marketing authorization holder).
- Inspection history and establishment listings for manufacturing sites associated with the product.
- Drug labeling sections that list the manufacturer/holder.
Key takeaways
- Primary supplier into the US market: Amneal Biosciences, LLC (labeler and commercial supplier for Gvoke Kit).
- Manufacturing partners: Final drug product and prefilled device assembly are performed by approved manufacturers coordinated through the labeler’s supply chain.
- Distribution: Gvoke Kit is distributed through major pharmaceutical distribution channels into retail pharmacies and health systems, coordinated by the labeler.
FAQs
Is Amneal the supplier of Gvoke Kit?
Yes. Amneal Biosciences, LLC is the US labeler and commercial supplier for GVOKE Kit.
Who manufactures the epinephrine in Gvoke Kit?
The epinephrine injection is produced through approved manufacturing partners under the product’s authorization and supply agreements coordinated by the labeler.
Can hospitals order Gvoke Kit through standard wholesalers?
Yes. Gvoke Kit is typically stocked and orderable through standard pharmaceutical wholesaler channels servicing hospitals and health systems.
Are there multiple manufacturing sites for Gvoke Kit?
Supply continuity typically uses qualified manufacturing lines and sites under approved arrangements, but the specific sites are tied to the product’s approved establishment listings.
Do generic epinephrine auto-injectors use the same suppliers as Gvoke Kit?
Not necessarily. Generic products can be manufactured and assembled by different qualified manufacturers under different labeler arrangements, even with the same active ingredient.
References
- FDA. “Drug Product Labeling and Product Data (NDC/Listing resources).” U.S. Food and Drug Administration. https://www.fda.gov/ (accessed 2026-06-03).
